SOX9 and cystic fibrosis: Concomitantly with decreased miR–129-5p expression in CF, we found that the expression of miR–129-5p targets SOX9 (Figure 2D) and ASPN (Figure 2E) in CF was upregulated in LV in patients with HF compared with controls, as assessed by immunofluorescence.